天津医药
天津醫藥
천진의약
TIANJIN MEDICAL JOURNAL
2014年
11期
1080-1083
,共4页
荆雪宁%邱波%战文翔%武继彪
荊雪寧%邱波%戰文翔%武繼彪
형설저%구파%전문상%무계표
黄芪多糖%树突细胞%白细胞介素4%干扰素Ⅱ型%抑瘤率%胸腺指数%脾脏指数%Th1/Th2
黃芪多糖%樹突細胞%白細胞介素4%榦擾素Ⅱ型%抑瘤率%胸腺指數%脾髒指數%Th1/Th2
황기다당%수돌세포%백세포개소4%간우소Ⅱ형%억류솔%흉선지수%비장지수%Th1/Th2
astragalan%dendritic cells%interleukin-4%interferon typeⅡ%tumor inhibition rate%thymus index%spleen index%Th1/Th2
目的:探讨黄芪多糖诱导成熟的树突状细胞(DC)肿瘤疫苗对S180荷瘤小鼠的抗肿瘤作用及作用机制。方法体外培养小鼠骨髓来源的DC,加入黄芪多糖诱导成熟,以S180肿瘤抗原致敏获得DC肿瘤疫苗。建立S180荷瘤小鼠模型,分为模型组、环磷酰胺组、黄芪多糖组、细胞因子组,在荷瘤第5天和第10天分别给予相应治疗。荷瘤第12天摘取肿瘤组织、胸腺、脾脏称质量,计算抑瘤率、胸腺指数、脾脏指数;ELISA法检测小鼠血清白细胞介素(IL)-4、干扰素(IFN)-γ水平。结果黄芪多糖组、细胞因子组的抑瘤率高于环磷酰胺组(64.25%、64.10%vs 35.11%),胸腺指数高于环磷酰胺组(1.69±0.26、1.74±0.38 vs 1.45±0.22),脾脏指数高于环磷酰胺组(5.44±0.76、5.31±0.81 vs 3.54±0.52),IL-4水平(ng/L)低于环磷酰胺组(15.66±2.57、14.72±4.84 vs 23.95±6.07),IFN-γ水平(ng/L)高于环磷酰胺组(16.54±3.71、17.20±2.03 vs 10.37±2.19),差异均有统计学意义。结论黄芪多糖诱导的DC疫苗可有效发挥抑瘤作用,其机制可能与提高荷瘤小鼠胸腺指数与脾脏指数,调节细胞因子表达,促进Th1/Th2失衡向Th1细胞占优势的细胞免疫偏移,增强机体的抗肿瘤免疫功能有关。
目的:探討黃芪多糖誘導成熟的樹突狀細胞(DC)腫瘤疫苗對S180荷瘤小鼠的抗腫瘤作用及作用機製。方法體外培養小鼠骨髓來源的DC,加入黃芪多糖誘導成熟,以S180腫瘤抗原緻敏穫得DC腫瘤疫苗。建立S180荷瘤小鼠模型,分為模型組、環燐酰胺組、黃芪多糖組、細胞因子組,在荷瘤第5天和第10天分彆給予相應治療。荷瘤第12天摘取腫瘤組織、胸腺、脾髒稱質量,計算抑瘤率、胸腺指數、脾髒指數;ELISA法檢測小鼠血清白細胞介素(IL)-4、榦擾素(IFN)-γ水平。結果黃芪多糖組、細胞因子組的抑瘤率高于環燐酰胺組(64.25%、64.10%vs 35.11%),胸腺指數高于環燐酰胺組(1.69±0.26、1.74±0.38 vs 1.45±0.22),脾髒指數高于環燐酰胺組(5.44±0.76、5.31±0.81 vs 3.54±0.52),IL-4水平(ng/L)低于環燐酰胺組(15.66±2.57、14.72±4.84 vs 23.95±6.07),IFN-γ水平(ng/L)高于環燐酰胺組(16.54±3.71、17.20±2.03 vs 10.37±2.19),差異均有統計學意義。結論黃芪多糖誘導的DC疫苗可有效髮揮抑瘤作用,其機製可能與提高荷瘤小鼠胸腺指數與脾髒指數,調節細胞因子錶達,促進Th1/Th2失衡嚮Th1細胞佔優勢的細胞免疫偏移,增彊機體的抗腫瘤免疫功能有關。
목적:탐토황기다당유도성숙적수돌상세포(DC)종류역묘대S180하류소서적항종류작용급작용궤제。방법체외배양소서골수래원적DC,가입황기다당유도성숙,이S180종류항원치민획득DC종류역묘。건립S180하류소서모형,분위모형조、배린선알조、황기다당조、세포인자조,재하류제5천화제10천분별급여상응치료。하류제12천적취종류조직、흉선、비장칭질량,계산억류솔、흉선지수、비장지수;ELISA법검측소서혈청백세포개소(IL)-4、간우소(IFN)-γ수평。결과황기다당조、세포인자조적억류솔고우배린선알조(64.25%、64.10%vs 35.11%),흉선지수고우배린선알조(1.69±0.26、1.74±0.38 vs 1.45±0.22),비장지수고우배린선알조(5.44±0.76、5.31±0.81 vs 3.54±0.52),IL-4수평(ng/L)저우배린선알조(15.66±2.57、14.72±4.84 vs 23.95±6.07),IFN-γ수평(ng/L)고우배린선알조(16.54±3.71、17.20±2.03 vs 10.37±2.19),차이균유통계학의의。결론황기다당유도적DC역묘가유효발휘억류작용,기궤제가능여제고하류소서흉선지수여비장지수,조절세포인자표체,촉진Th1/Th2실형향Th1세포점우세적세포면역편이,증강궤체적항종류면역공능유관。
Objective To study the antitumor effects of dendritic cell vaccine induced by astragalus polysaccha?rides on S180 tumor-bearing mice, and its possible mechanism. Methods Dendritic cells derived from mouse bone marrow were induced maturation by astragalus polysaccharides and loaded with S180 tumor antigen to prepare tumor vaccine. Tu?mor-bearing mice were divided into four groups and treated on day-5 and day-10 respectively. Group A was injected with NS, Group B with CTX (50 mg/kg), Group C with dendritic cells induced by astragalus polysaccharides and Group D with dendritic cells induced by tumor necrosis factor (TNF)-α. After 12 days of tumor-bearing, the animals were killed. The sub?cutaneous sarcoma, thymus and spleen were separated and weighted. The inhibitory rate, thymus index and spleen index were then calculated. ELISA assay was used to detect the levels of interleukin (IL)-4, interferon (IFN)-γin serum of tumor bearing mice. Results The tumor inhibition rate was higher in astragalus polysaccharide group and cytokine group than that of CTX group (64.25%, 64.10%vs 35.11%). The thymus index was higher in astragalus polysaccharide group and cyto?kine group than that of CTX group (1.69 ± 0.26, 1.74 ± 0.38 vs 1.45 ± 0.22). The spleen index was higher in astragalus poly?saccharide group and cytokine group than that of CTX group (5.44 ± 0.76, 5.31 ± 0.81 vs 3.54 ± 0.52). The level of IL-4 was lower in astragalus polysaccharide group and cytokine group than that of CTX group (15.66±2.57, 14.72 ± 4.84 vs 23.95 ± 6.07). The level of IFN-γwas higher in astragalus polysaccharide group and cytokine group than that of CTX group (16.54 ± 3.71, 17.20 ± 2.03 vs 10.37 ± 2.19). All the differences were statistically significant (P<0.05). Conclusion Dendritic cell vaccine induced by astragalus polysaccharides can effectively inhibit tumor growth. Its mechanism may be associated with the promotion spleen index and thymus index of S180 tumor-bearing mice, the effective correction of Th1/Th2 imbalance in?duced by tumor, and the enhancement of antitumor immune responses.